Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials
- Resource Type
- Article
- Source
- In
The Lancet Diabetes & Endocrinology November 2020 8(11):880-893 - Subject
Primary Research Articles - Language
- ISSN
- 2213-8587